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Abstract: 
During radiotherapy for gastric lymphoma, it is difficult to protect 
the liver and kidneys in cases where there is considerable overlap 
between these organs and the target volume. This study was 
conducted to compare the three radiotherapy planning techniques 
of four-fields 3D conformal radiotherapy (3DCRT), half-field 
radiotherapy (the half-beam method) and intensity-modulated 
radiotherapy (IMRT) used to treat primary gastric lymphoma in 
which the planning target volume (PTV) had a large overlap with 
the left kidney. A total of 17 patients with gastric diffuse large 
B-cell lymphoma (DLBCL) were included. In DLBCL, 
immunochemotherapy (Rituximab + CHOP) was followed by 
radiotherapy of 40 Gy to the whole stomach and peri-gastric 
lymph nodes. 3DCRT, the half-field method, and IMRT were 
compared with respect to the dose–volume histogram 
(DVH) parameters and generalized equivalent uniform dose 
(gEUD) to the kidneys, liver and PTV. The mean dose and gEUD 
for 3DCRT was higher than for IMRT and the half-beam method 
in the left kidney and both kidneys. The mean dose and gEUD of 
the left kidney was 2117 cGy and 2224 cGy for 3DCRT, 1520 
cGy and 1637 cGy for IMRT, and 1100 cGy and 1357 cGy for the 
half-beam method, respectively. The mean dose and gEUD of 
both kidneys was 1335 cGy and 1559 cGy for 3DCRT, 1184 cGy 
and 1311 cGy for IMRT, and 700 cGy and 937 cGy for the 
half-beam method, respectively. Dose–volume histograms 
(DVHs) of the liver revealed a larger volume was irradiated in the 
dose range <25 Gy with 3DCRT, while the half-beam method 
irradiated a larger volume of liver with the higher dose range  
(>25 Gy). IMRT and the half-beam method had the advantages 
of dose reduction for the kidneys and liver. 
 
 
 
 
 
 
INTRODUCTION: 
Primary gastric lymphomas are mainly consists of 
mucosaassociated lymphoid tissue (MALT) lymphoma and 
diffuse large B-cell lymphoma (DLBCL). While standard 
treatment of gastric MALT lymphoma refractory to Helicobacter 
pylori (HP) sterilization is radiotherapy of ~30 Gy with 
conventional fractionation [1, 2], localized gastric DLBCL is 
treated with immunochemotherapy and ensuing radiotherapy 
of ~30–40 Gy with conventional fractionation [3, 4]. The 
clinical target volume (CTV) for gastric lymphoma is the 
whole stomach and neighboring peri-gastric lymph node stations. 
The stomach shows physiological motions due to respiration 
and peristalsis, which necessitates large margins being added to 
the CTV to set up the internal target volume (ITV). During 
radiotherapy of the stomach, the main organs at risk (OARs) are 
the kidneys and liver. Meticulous attention should be paid to 
kidney and liver tolerances because they are relatively sensitive to 
radiation. The tolerance dose is expressed as TD5/5 and TD50/5, 
indicating the doses at which late morbidity is seen in 5% and 
50% respectively in 5 years. TD5/5 and TD50/5 for whole kidney 
irradiation are 23 Gy and 28 Gy, respectively. Also, TD5/5 and 
TD50/5 for whole liver irradiation have been reported to be 30 Gy 
and 40 Gy, respectively [5]. Radiation effects to the kidneys 
and liver were recently summarized in the QUANTEC study 
[6, 7, 8]. 
There are numerous reports about treatment planning for 
the abdominal region, e.g. gastric carcinoma [9] or pancreas 
carcinoma and/or bile duct malignancies [10, 11], and many 
reports indicate the advantages of intensity-modulated 
radiotherapy (IMRT). For gastric lymphoma, however, there are 
few reports about radiation treatment planning. In one such 
report, Della et al. classified gastric lymphoma into three types 
according to the amount of overlap between the kidney and the 
planning target volume (PTV). In cases with a large overlap 
between the kidney and the PTV, it is difficult to protect the 
kidney when using radiation of AP/PA opposing fields; in these 
cases, 3D conformal radiation therapy (3DCRT) is more 
advantageous. Use of IMRT might lead to further improvement 
for the left kidney and liver doses [12]. Additionally, Ringash et 
al. reported a five-fields technique for postoperative radiotherapy 
of gastric cancer. In this technique, the target volume is divided at 
the isocenter, which is typically placed at the level of the upper 
end of the left kidney. The volume superior to this isocenter is 
treated with AP/PA half-beam opposing fields, wheras the 
inferior volume is irradiated with an anterior and two half-beam 
wedged lateral fields. The resulting anterior fields irradiate the 
superior and inferior volumes with a single isocenter. A junctional 
move of 1 cm superiorly is planned after 10 fractions. This 
method was used to treat 20 patients, and acute toxicity was 
reduced to 25%, which is lower than the 41% observed in 
INT0116 [13]. INT0116 was a phase III study of 
chemoradiotherapy (fluorouracil plus leucovorin and 45 Gy/25 
fractions to the tumor bed, regional nodes and 2 cm beyond the 
proximal and distal margins of resection) after surgery versus 
surgery alone for adenocarcinoma of the stomach or 
gastroesophageal junction [14].We modified the method of 
Ringash et al. by deleting the lower half of the anterior field so as 
to reduce the dose to the left kidney. This half-beam method 
uses superior AP/PA half-beam fields and inferior LR/RL 
half-beam fields. The current planning study was conducted on 
difficult cases with a large overlap between the kidney and the 
PTV, comparing the three planning techniques of 3DCRT, the 
half-beam method and IMRT. 
 
MATERIALS AND METHODS: 
The radiation oncology database was searched for gastric 
DLBCL treated with radiotherapy of ~40 Gy/20 fractions from 1 
January 2000 to 31 December 2012, whose 3D CT data was 
available for radiation planning. Eligible patients had an overlap 
of >50% between the left kidney and the PTV in an AP projection 
in digitally reconstructed radiography (DRR). Patients were 
instructed to fast before treatment. In some patients, scopolamine 
butylbromide was used to suppress peristalsis. For X-ray 
simulation, a small amount of barium was swallowed to examine 
the degree of peristalsis. The CTV was defined as the whole 
stomach plus the neighboring peri-gastric lymph nodes. Planning 
CT was obtained in shallow exhale and inhale phases, and CTVs 
in both phases were fused and margins of peristalsis were added 
to obtain the ITV. The PTV was expanded 1 cm in all directions 
from the ITV to cover inter- and intra-fractional gastric motion 
and the set-up margin. On-board imaging (OBI) was used to 
confirm the fields covered the target sufficiently with a small 
amount of barium during treatment. During radiotherapy planning, 
the kidneys were contoured as the renal parenchyma excluding 
renal calyces. The three plans of 3DCRT, the half-beam method 
and IMRT were constructed using beam data generated by 15-MV 
X-rays from a linear accelerator (Clinac iX Linear accelerator, 
Varian, Palo Alto, CA). In 3DCRT, AP/PA or oblique fields and 
LR/RL fields or oblique fields were set up that covered the PTV 
adequately. In the half-beam method, the isocenter was set at the 
upper end of the left kidney, and the upper half of the PTV was 
treated using half-beam AP/PA or oblique fields with the 
reference point set to the central point of the field, while the lower 
half was irradiated with half-beam RL/LR or oblique lateral fields 
with the reference point set to the central point of the field. The 
junction was moved once a week. In the 3DCRT and half-beam 
methods, 40 Gy was applied to the isocenter. Nine fields at gantry 
angles of 0°, 35°, 60°, 110°, 165°, 210°, 290°, 315° and 340° 
were used in the IMRT treatment plan. Doses to the kidney and 
the liver were reduced to as low as possible, and the dose 
prescription in the IMRT treatment plan was defined by 95% of 
the PTV (D95) being irradiated to an equal dose to the 3DCRT 
planning. Dose–volume histograms (DVHs) of the PTV, the liver, 
the right kidney, left kidney and both kidneys were analyzed. The 
mean dose and generalized equivalent uniform dose (gEUD) were 
compared between the three treatment plans. The gEUD is the 
uniform whole-organ dose that would cause equivalent biologic 
effect to the inhomogeneous dose distribution in the relevant 
organ. The gEUD can be obtained using the formula 
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where vi is the fractional organ volume receiving a dose Di and a 
is a tissue-specific parameter that represents the volume effect. 
In the statistical analysis, each parameter was analyzed by 
non-parametric comparison. A P value < 0.0167 was considered 
significant when two of the three plans were evaluated (multiple 
comparison, Bonferroni method). Our institutional review board 
(the National Cancer Center Institutional Review Board) 
approved this study, and treatment was carried out with written 
informed consent. 
 
RESULTS: 
A total of 92 patients with gastric DLBCL underwent 
postchemotherapy radiation therapy in the study period; 17 of the 
92 patients (18.5%) were classified as ‘difficult’ cases with a 
large overlap of the left kidney and the PTV, and were thus 
included in this study. Average DVHs for the three plans are 
shown in Fig. 1. The mean dose and the gEUD of the three plans 
are summarized in Table 1. Comparing the DVHs in the dose 
range <15 Gy, an increasing volume of the right kidney was 
irradiated by the half-beam method, 3DCRT and IMRT (in that 
order). In the dose range >25 Gy, the DVHs of the three plans 
converged with one another. The resulting mean dose and gEUD 
of the right kidney for IMRT was higher than for 3DCRT and the 
half-beam method with statistical significance. The mean dose for 
IMRT was 835 cGy, for 3DCRT was 519 cGy (P = 0.0012) and 
for the half-beam method was 283 cGy (P < 0.0001). The gEUD 
for IMRT was 913 cGy, for 3DCRT was 622 cGy (P = 0.0043) 
and for the half-beam method was 344 cGy (P < 0.0001). 
Similarly, in the dose range <25 Gy, an increasing volume of the 
left kidney was irradiated using the half-beam method, IMRT, 
and 3DCRT (in that order). In the higher dose range (>25 Gy), the 
DVHs of the three plans showed no difference. The resulting 
mean dose and the gEUD for 3DCRT was higher than for IMRT 
and the half-beam method, with the difference between the 
half-beam method and 3DCRT reaching statistical significance. 
The mean dose for 3DCRT was 2117 cGy, for IMRT was 1520 
cGy (P = 0.023) and for the half-beam method was 1100 cGy (P = 
0.0003). The gEUD for 3DCRT was 2224 cGy, for IMRT was 
1637 cGy (P = 0.0192) and for the half-beam method was 1357 
cGy (P = 0.0017). Regarding the DVHs for both kidneys, in the 
low dose range (<10 Gy) an increasing volume of both kidneys 
was irradiated using the half-beam method, 3DCRT and IMRT 
(in that order), while in the moderate dose range (between 10 Gy 
and 25 Gy) an increasing volume of both kidneys was irradiated 
using the half-beam method, IMRT and 3DCRT (in that order); 
for >25 Gy the DVHs of the three plans converged with one 
another. The resulting mean dose and the gEUD for both kidneys 
using 3DCRT and IMRT was higher than using the half-beam 
method with statistical significance. The mean dose for the 
half-beam method was 700 cGy, for 3DCRT was 1335 cGy (P < 
0.0001) and for IMRT was 1184 cGy (P = 0.0002). The gEUD 
using the half-beam method was 937 cGy, using 3DCRT was 
1559 cGy (P = 0.0002) and using IMRT was 1311 cGy (P = 
0.0034). In the DVHs of the liver, a larger volume was irradiated 
using 3DCRT in the dose range <25 Gy, while the half-beam 
method irradiated a larger volume of the liver in the higher dose 
range. Although the mean dose of the liver was largest using 
3DCRT (the mean dose using 3DCRT was 2115 cGy, using the 
half-beam method was 1520 cGy (P = 0.0003) and using IMRT 
was 1135 cGy (P < 0.0001)), the gEUD was largest using the 
half-beam method because the half-beam method exposed a larger 
volume of the liver in the dose range >25 Gy (the gEUD using the 
half-beam method was 2746 cGy, using 3DCRT was 2656 cGy (P 
= 0.2856) and using IMRT was 1976 cGy (P < 0.0001)). 
 
DISCUSSION: 
In radiotherapy for gastric lymphoma, cases with a small overlap 
between the left kidney and the PTV are easy for radiotherapy 
planning, but for cases with a large overlap between them, OAR 
dose reduction is very difficult. We conducted this study to 
compare dose distributions for 3DCRT, the half-beam method 
and IMRT to establish the benefits of each radiation method in 
difficult cases where there is a large overlap between the left 
kidney and the PTV. The half-beam method and IMRT showed a 
great advantage over 3DCRT in reducing the doses to the left 
kidney and liver. This planning study revealed that the half-beam 
method and IMRT were appropriate treatment plans for cases 
with a large overlap between the left kidney and the PTV in terms 
of reducing the doses to the left kidney and liver. The half-beam 
method irradiated the bilateral kidneys with the lowest dose, 
which may be quite important for the possible future 
administration of chemotherapy. However, the half-beam method 
had a disadvantage in that the high-dose region of the liver was 
larger. Meanwhile, IMRT had a tendency for the mean dose to the 
kidney being larger than for the half-beam method. The tolerance 
dose of the kidneys is lower than that of the liver; therefore, the 
half-beam method seems to be preferable to IMRT. However, the 
dose distribution for IMRT can be altered by changing the setting 
of the priority parameters of the OARs during planning; thus, it 
was difficult to decide whether IMRT or the half-beam method 
was more suitable. It seems advisable to make plans both using 
the half-beam method and IMRT and then to compare them with 
respect to the DVHs to decide which plan will be more suitable. 
Lately, localized DLBCL has sometimes been treated by 
R-CHOP alone; therefore, these difficult cases could be 
candidates for immune-chemotherapy alone. In the QUANTEC, 
the tolerance dose for both kidneys is reported to be ~15–18 Gy in 
mean dose, and the tolerance dose for the normal liver is reported 
to be ~30–32 Gy in mean dose [8]. However, there have been 
some reports showing that late renal toxicity occurs even under 
15–18 Gy in long-term follow-up study of patients undergoing 
total-body irradiation (TBI) [16, 17, 18]. Cheng et al. reported 
that the dose associated with a 5% risk of kidney toxicity is 9.8 
Gy [17]. Patients of primary gastric lymphoma (PGL) have good 
prognosis; thus, they would be long-time survivors. Therefore, 
from the standpoint of keeping adequate renal functions in the 
long term, the dose to the kidneys should be kept even lower than 
15–18 Gy. Further study of the DVHs of the kidney and liver 
associated with long-term adequate kidney and liver functions is 
needed. It would also be beneficial to investigate whether the 
half-beam method or IMRT are more suitable for treatment of 
PGL patients. 
 
 
CONCLUSION: 
This study shows an advantage for the half-beam method and 
IMRT over 3DCRT in the treatment of post-chemotherapy gastric 
DLBCL in cases where there is a large overlap between the 
kidney and the PTV. 
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Legend for Table and Figure: 
 
Table 1. Mean doses and gEUDs of right, left and both kidney 
and liver according to 3DCRT, half beam method and IMRT. 
 
Fig 1. Average DVH comparing 3DCRT, half beam method and 
IMRT. Fig1a: DVH of PTV, Fig 1b: DVH of the right kidney, 
Fig. 1c:DVH of the left kidney, Fig. 1d:DVH of the both kidney, 
Fig. 1e:DVH of the liver. 
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